Intrexon | XON - Trade Creditors


Intrexon reported $4.85M in Trade Creditors for its fiscal quarter ending in June of 2024.





Trade Creditors Change Date
Agenus USD 82.99M 2.3M Dec/2025
Alaunos Therapeutics USD 843K 34K Sep/2025
Amgen USD 20.89B 1.25B Dec/2025
Anika Therapeutics USD 6.04M 1.31M Dec/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
AstraZeneca USD 25.28B 252M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Gilead Sciences USD 808M 226M Sep/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Incyte USD 1.63B 1.46B Dec/2025
Intrexon USD 4.85M 3.12M Jun/2024
Karyopharm Therapeutics USD 5.39M 2.8M Sep/2025
Ligand Pharmaceuticals USD 3.24M 24.52M Dec/2025
MacroGenics USD 4.79M 1.15M Dec/2025
MannKind USD 9.03M 1.76M Dec/2025
Merck USD 4.15B 102M Sep/2025
Novartis USD 4.46B 99M Dec/2025
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Roche Holding CHF 5.78B 1.27B Dec/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Thermo Fisher Scientific USD 3.62B 502M Dec/2025
Veracyte USD 4.59M 916K Dec/2025
Xencor USD 10.83M 1.75M Dec/2025